Extrapyramidal symptoms and residual psychopathology with low-dose neuroleptics

Human Psychopharmacology

Volumn 15, Issue 2, 2000, Pages 79-85

  Berardi, Domenico ^a,b   Giannelli, Annalisa ^a   Biscione, Roberto ^a   Ferrari, Giuseppe ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Istituto di Psichiatria   (Italy)

Author keywords

Akathisia; Antipsychotic drugs; Antipsychotic low doses; Out patients; Parkinsonism; Residual psychopathology; Subjective effect

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; AKATHISIA; ANXIETY; ARTICLE; DEPRESSION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PARKINSONISM; PRIORITY JOURNAL; SCHIZOPHRENIA; SIDE EFFECT;

EID: 0034115112     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(200003)15:2<79::AID-HUP146>3.0.CO;2-6     Document Type: Article

References (36)

1. Academic Highlights (1993). Neuroleptic-Induced Deficit Syndrome (NIDS). Journal of Clinical Psychiatry, 54, 493-500.
2. American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM III-R). APA, Washington, DC.
3. Barnes, T. R. E. (1989). A rating scale for drug-induced akathisia. British Journal of Psychiatry, 154, 672-676.
4. Barnes, T. R. E. and Braude, W. M. (1985). Akathisia variants and tardive dyskinesia. Archives of General Psychiatry, 42, 874-878.
5. Barnes, T. R. E. and Liddle, P. F. (1990). Evidence for the validity of negative symptoms. Andreasen, N. C. (Ed.), Karger, Basel, pp. 43-72.
6. Braude, W. M., Barnes, T. R. E. and Gore, S. M. (1983). Clinical characteristics of akathisia. A systematic investigation of acute psychiatric in-patient admissions. British Journal of Psychiatry, 143, 139-150.
7. Carpenter, W. T. Jr. (1996). The treatment of negative symptoms: pharmacological and methodological issues. British Journal of Psychiatry, 168(supp. 29), 17-22.
8. Carpenter, W. T. Jr., Heinrich, D. W. and Alphs, L. D. (1985). Treatment of negative symptoms. Schizophrenia Bulletin, 11, 440-452.
9. Carpenter, W. T. Jr., Heinrich, D. W. and Wagman, A. M. I. (1988). Deficit and nondeficit forms of schizophrenia: the concept. American Journal of Psychiatry, 145, 578-583.
10. Drake, R. E. and Ehrlich, J. (1985). Suicide attempts associated with akathisia. American Journal of Psychiatry, 142, 499-501.
11. Gelemberg, A. J., Doller, J. C., Schooler, N. R., Mieske, M., Severe, J. and Mandel, M. R. (1979). Acute extrapyramidal reactions with fluphenazine hidrochloride and fluphenazine decanoate. American Journal of Psychiatry, 136, 217-219.
12. Halstead, S. M., Barnes, T. R. E. and Speller, J. C. (1994). Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia. British Journal of Psychiatry, 164, 177-183.
13. Keckich, W. A. (1978). Violence as a manifestation of akathisia. Journal of American Medical Association, 240, 2185.
14. Levinson, D. F., Simpson, G. M., Singh, H., Yadalam, K., Jain, A., Stephanos, M. J. and Silver, P. (1990). Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment. Archives of General Psychiatry, 47, 761-768.
15. Levinson, D. F., Simpson, G. M., Lo, E. S., Cooper, T. B., Singh, H., Yadalam, K. and Stephanos, M. J. (1995). Fluphenazine plasma levels, dosage, efficacy, and side effects. American Journal of Psychiatry, 152, 765-771.
16. Marder, S. R., Van Putten, T., Mintz, J., McKenzie, J., Lebell, I., Faltico, G. and May, P. R. A. (1984). Costs and benefit of two doses of fluphenazine. Archives of General Psychiatry, 41, 1025-1029.
17. Marsden, C. D., Mindham, R. H. and Mackay, A. V. (1986). Extrapyramidal movement disorders produced by antipsychotic drugs. The Psychopharmacology and Treatment of Schizophrenia, Bradley, P. B. and Hirsch, S. R. (Eds), Oxford University Press, Oxford, pp. 340-402.
18. McCreadie, R. G., Robertson, L. J. and Wiles, D. H. (1992). The Nithsdale schizophrenia surveys IX: akathisia, parkinsonism, tardive dyskinesia and plasma neuroleptic levels. British Journal of Psychiatry, 160, 793-799.
19. Newcomer, J. W., Miller, L. S., Faustman, W. O., Wetzel, M. W., Vogler, G. P. and Csernansky, J. G. (1994). Correlations between akathisia and residual psychopathology: a by-product of neuroleptics-induced dysphoria. British Journal of Psychiatry, 164, 834-838.
20. Overall, J. E. and Gorham, D. R. (1962). The Brief Psychiatry Rating Scale. Psychological Report, 10, 799-812.
21. Prosser, E. S., Csernansky, J. G., Kaplan, J., Thiemann, S., Becker, T. J. and Hollister, L. E. (1987). Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics. Journal of Nervous and Mental Disease, 175(2), 100-105.
22. Rey, M. J., Schulz, P., Costa, C., Dick, P. and Tissot, R. (1989). Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. International Clinical Psychopharmacology, 4, 95-104.
23. Rifkin, A., Quitkin, F. and Klein, D. F. (1975). Akinesia. A poorly recognised drug induced extra-pyramidal behavioural disorder. Archives of General Psychiatry, 32, 672-675.
24. Rifkin, A., Quitkin, F., Rabiner, C. J. and Klein, D. F. (1977). Fluphenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics. I. Relapse rates after one year. Archives of General Psychiatry, 34, 43-47.
25. Shaw, E. D., Mann, J. J. and Widen, P. J. (1986). A case of suicidal and homicidal ideation and akathisia in a double-blind neuroleptic crossover study. Journal of Clinical Psychopharmacology, 6, 196.
26. Shear, M. K., Frances, A. and Weiden, P. (1983). Suicide associated with akathisia and depot flufenazina treatment. Journal of Clinical Psychopharmacology, 4, 235-236.
27. Shulte, J. R. (1985). Homicide and suicide associated with akathisia and haloperidol. American Journal of Forensic Psychiatry, 6, 3-8.
28. Siris, S. G. (1985). Three cases of akathisia and "acting out". Journal of Clinical Psychiatry, 46, 395-397.
29. Simpson, G. M. and Angus, J. W. S. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica, 212(S44), 11-19.
30. Snaith, R. P., Bridge, G. W. K. and Hamilton, M. (1976). The Leeds Scales for the self-rating of anxiety of depression. British Journal of Psychiatry, 128, 156-165.
31. Van Putten, T. and May, P. (1978a). Subjective response as a predictor of outcome in pharmacotherapy. Archives of General Psychiatry, 35, 477-480.
32. Van Putten, T. and May, P. (1978b). "Akinetic depression" in schizophrenia. Archives of General Psychiatry, 35, 1101-1107.
33. Van Putten, T., Crumpton, E. and Yale, C. (1976). Drug refusal in schizophrenia and the wish to be crazy. Archives of General Psychiatry, 33, 1443-1446.
34. Van Putten, T., May, P. R. A., Marder, S. R. and Wittmann, L. A. (1981). Subjective response to antipsychotic drugs. Archives of General Psychiatry, 38, 187-190.
35. Van Putten, T, May, P. R. A., Marder, S. R. (1984). Response to antipsychotic medication: the doctor's and the consumer's view. American Journal of Psychiatry, 141, 16-19.
36. Van Putten, T., Marder, S. R. and Mintz, J. (1990). A controlled dose comparison of haloperidol in newly admitted schizophrenic patients. Archives of General Psychiatry.